Assessing the prognostic value of stemness-related genes in breast cancer patients

Wen-Jie Wang1, Han Wang2, Meng-Sen Wang3

  • 1Department of Radio-Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, 26 Daoqian Street, Suzhou, 215001, Jiangsu, People's Republic of China.

Scientific Reports
|October 28, 2020
PubMed

Insights

This study identifies four stemness-related genes (PSMB9, CXCL13, NPR3, CDKN2C) crucial for breast cancer stem cells (BCSCs). A prognostic model using these genes predicts patient survival, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer (BC) remains a leading cause of cancer mortality globally.
  • Cancer stem cells (CSCs) contribute to treatment resistance and tumor recurrence in BC.
  • Eliminating CSCs is critical for effective breast cancer treatment.

Purpose of the Study:

  • To identify stemness-related genes in breast cancer.
  • To develop a prognostic model for breast cancer patients based on these genes.
  • To explore potential therapeutic targets within breast cancer stem cells (BCSCs).

Main Methods:

  • Differential gene expression analysis using the edgeR package on GSE69280 dataset.
  • Prognostic model construction via Lasso-penalized and univariate Cox regression.
  • Model validation using TCGA and GSE24450 datasets, employing nomograms and ROC curves.

Main Results:

  • Identified stemness-related differentially expressed genes.
  • Developed a prognostic model using four genes: PSMB9, CXCL13, NPR3, and CDKN2C.
  • Validated the model's accuracy and found that a low-risk score correlated with better overall survival (OS) in both TCGA and GSE24450 datasets.

Conclusions:

  • A novel prognostic model for breast cancer was established using four stemness-related genes.
  • This model accurately predicts patient outcomes and can identify breast cancer stem cells (BCSCs).
  • The identified genes represent potential therapeutic targets for improving breast cancer treatment efficacy.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.1K